Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 14291 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 2, 2022, 

Meridian Medical Technologies, LLC, 

2555 Hermelin Drive, Saint Louis, 

Missouri 63144, applied to be registered 

as an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Morphine ......................... 9300 II 

The company plans to import the 

control substance for analytical and 

research purposes. No other activity for 

this drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05291 Filed 3–11–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–981] 

Importer of Controlled Substances 

Application: Sigma Aldrich Co. LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Co. LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 13, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before April 13, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 21, 2022, 

Sigma Aldrich Co. LLC, 3500 Dekalb 

Street, Saint Louis, Missouri 63118– 

4103, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug code Schedule 

Cathinone ............................................................................................................................................................................... 1235 I 

Methcathinone ........................................................................................................................................................................ 1237 I 

Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................... 1248 I 

Gamma Hydroxybutyric Acid .................................................................................................................................................. 2010 I 

Tetrahydrocannabinols ........................................................................................................................................................... 7370 I 

4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................. 7392 I 

2,5-Dimethoxyamphetamine ................................................................................................................................................... 7396 I 

3,4-Methylenedioxyamphetamine ........................................................................................................................................... 7400 I 

3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................. 7404 I 

3,4-Methylenedioxymethamphetamine ................................................................................................................................... 7405 I 

4-Methoxyamphetamine ......................................................................................................................................................... 7411 I 

Dimethyltryptamine ................................................................................................................................................................. 7435 I 

N-Benzylpiperazine ................................................................................................................................................................ 7493 I 

Heroin ..................................................................................................................................................................................... 9200 I 

Normorphine ........................................................................................................................................................................... 9313 I 

Amobarbital ............................................................................................................................................................................ 2125 II 

Secobarbital ............................................................................................................................................................................ 2315 II 

Nabilone ................................................................................................................................................................................. 7379 II 

Phencyclidine ......................................................................................................................................................................... 7471 II 

Ecgonine ................................................................................................................................................................................. 9180 II 

Ethylmorphine ......................................................................................................................................................................... 9190 II 

Levorphanol ............................................................................................................................................................................ 9220 II 

Meperidine .............................................................................................................................................................................. 9230 II 

Thebaine ................................................................................................................................................................................. 9333 II 

Opium, powdered ................................................................................................................................................................... 9639 II 

Levo-alphacetylmethadol ........................................................................................................................................................ 9648 II 


jspears on DSK121TN23PROD with NOTICES1
14292 Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 

The company plans to import the 

listed controlled substances for sale to 

research facilities for drug testing and 

analysis. In reference to drug code 7370 

(Tetrahydrocannabinols) the company 

plans to import synthetic 

Tetrahydrocannabinols. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05318 Filed 3–11–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–977] 

Importer of Controlled Substances 

Application: Perkinelmer, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Perkinelmer, Inc. has applied 

to be registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTAL INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before April 13, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before April 13, 2022. 

ADDRESSES: The DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 7, 2022, 

Perkinelmer, Inc., 120 East Dedham 

Street, Boston, Massachusetts 02118– 

2852, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Lysergic Acid Diethylamide ...... 7315 I 

Thebaine ................................... 9333 II 

The company plans to import the 

listed controlled substances for bulk 

manufacturing into radioactive 

formulations for sale to its customers for 

research purposes. Drug code 9333 

(Thebaine) will be used to import the 

Thebaine derivative Diprenorphine. No 

other activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–05308 Filed 3–11–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–983] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: 

Agriculture Technology Institute, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 13, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

submit electronic comments on or 

objections of the requested registration, 

as provided in this notice. This notice 

does not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 


jspears on DSK121TN23PROD with NOTICES1